共 50 条
- [42] 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (10) : 981 - 991
- [43] Comment on "Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial'' REVISTA PORTUGUESA DE CARDIOLOGIA, 2017, 36 (01) : 73 - 75
- [45] Everolimus-eluting Stent for the treatment of de novo coronary lesions: B-angiographic follow-up of the FUTURE trial AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 61L - 61L
- [47] ASPECT study: 2-year follow-up of a polymer-free paclitaxel-eluting coronary stent AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 59L - 60L